Clinical Trial Update: A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled trial evaluating VP-102 for external genital warts has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Condylomata Acuminata
• Human Papillomavirus Infection

Drugs mentioned

• VP-102 (cantharidin topical solution)

Snippet

Sponsor: Verrica Pharmaceuticals Inc. | Conditions: Condylomata Acuminata, Papillomavirus Infections | Phase 2 | Status: COMPLETED | Results posted: 2021-09-22